NEW YORK, Sept. 22 (GenomeWeb News) - Ingenuity Systems said today that GlaxoSmithKline has licensed part of its Pathways Knowledge Base database.
Ingenuity said that GSK would use the database - which maps relationships between proteins, genes, complexes, cells, tissues, drugs, and diseases - as part of its internal computational genomics effort.
Further details about the licensing agreement were not provided.